<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".01" citation="COMAR 10.52.05.01" title_num="10" subtitle_num="52" chapter_num="05" heading="Definitions.">
  <paragraph num="A.">
    <text>“Department” means the Maryland Department of Health.</text>
  </paragraph>
  <paragraph num="B.">
    <text>“Health care provider” means any licensed health care professional, organization, or institution, whether public or private, under whose authority pertussis vaccine is administered.</text>
  </paragraph>
  <paragraph num="C.">
    <text>“Major adverse reaction” means any:</text>
    <paragraph num="(1)">
      <text>Serious illness, disability, or impairment of mental, emotional, behavioral, or physical functioning or development, the first manifestation of which appears within 7 days after the date of administration of pertussis vaccine and for which there is reasonable scientific or medical evidence pertussis vaccine causes, or significantly contributes to, the effect; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Other reaction which the Department, after consultation with the Medical and Chirurgical Faculty of Maryland, determines is a basis for not continuing with pertussis vaccine administration.</text>
    </paragraph>
  </paragraph>
  <paragraph num="D.">
    <text>“Patient” means the individual to whom pertussis vaccine is being administered.</text>
  </paragraph>
  <paragraph num="E.">
    <text>“Pertussis vaccine” means any vaccine that contains materials intended to prevent the occurrence of pertussis, whether the materials are administered separately or in conjunction with other materials intended to prevent the occurrence of other diseases.</text>
  </paragraph>
</regulation>